Aim This narrative review aims to describe established and emerging urinary biomarkers in
the diagnosis and surveillance of non-muscle invasive bladder cancer. It provides a …

Bladder cancer (BC) is a common malignancy in the genitourinary system and the current
theranostic approaches are unsatisfactory. Sensitivity and specificity of current diagnosis …

Currently available point-of-care tests for Bladder Cancer (BC) are qualitative and prone to
high false positives, thus preventing them from replacing clinical cystoscopy as reliable …

Bladder cancer greatly endangers human health, and its early diagnosis is of vital
importance. Exosomes, which contain proteins and nucleic acids related to their source …

Designing functional materials as electrode coatings to transduce high‐quality information
about redox molecules in biofluids is crucial for developing the next‐generation medical …

Background Patients with metastatic bladder cancer have very poor prognosis and
predictive biomarkers are urgently needed for early clinical detection and intervention. In this …

Background The development of accurate urinary biomarkers for non-invasive and cost-
effective detection of primary and recurrent bladder tumours is recognized as one of the …

The types of urothelial carcinoma (UC) include urothelial bladder cancer and upper tract
urothelial carcinoma. Current diagnostic techniques cannot meet the needs of patients …

Background Bladder cancer (BC) is a commonly occurring malignant tumor of the urinary
system, demonstrating high global morbidity and mortality rates. BC currently lacks widely …

Bladder cancer is one of the most common malignant tumors of the urinary system with a
significantly increased incidence in recent years. Tumor biomarkers detection with high …